Filter by

  • Publication Year
  • Availability
  • Attachment
  • Collection Type
    See More
  • General Material Designation
    See More
  • Location
    See More
  • Language
Found 6 from your keywords: subject="Redacid"
cover
Relative potency of proton-pum p inhibitors—comparison of effe cts on int r…
Comment Share
Julia Kirchheiner

Comparative potency of proton-pump inhibitors (PPIs) is an important clinical issue. Most available trials have compared the different PPIs at one or a few selected specific dosages, making it difficult to derive quantitative equivalence dosages. Here we derived PPI dose equivalents based on a comprehensive assessment of dose-dependent effects on intragastric pH

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Gastroprotective Effect of DLBS2411 Bioactive Fraction from Cinnamomum burman…
Comment Share
Tjandrawinata RR

The study was carried out to evaluate the anti-ulcerative and gastroprotective effect of DLBS2411, a bioactive fraction from Cinnamomum burmannii (Nees & T. Nees) Blume, in Wistar rats (Rattus norvegicus)

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Hydrogen potassium adenosine triphosphatase activity inhibition and downregul…
Comment Share
Tjandrawinata RR

This study assessed the gastric acid antisecretory effect of DLBS2411 fractionated from Cinnamomum burmannii. Hydrogen potassium adenosine triphosphatase (H+/K+ ATPase) activity and its gene expression were observed, and the antioxidant activity of DLBS2411 was also investigated. Treatment of DLBS2411 decreased the level of H+/K+ ATPase messenger RNA expression on human embryonic kidney 293 cel…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
BIOACTIVE FRACTION DLBS2411 FROM CINNAMOMUM BURMANNII, (NEES AND T. NEES) BLU…
Comment Share
Wulandari AS

Mucus therapy is one of the therapies for gastric ulcer management aside from proton pump inhibitor (PPI) and H2-blocker medication. Bioactive fraction DLBS2411 which comes from Cinnamomum burmannii has been identified as a gastric acid anti-secretory agent by inhibiting the activity of hydrogen-potassium adenosine triphosphate (H+/K+ATPase). The study was aimed to evaluate the effect of DL…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Clinical Drug–Drug Pharmacokinetic Interaction Potential of Sucralfate with…
Comment Share
Sulochana SP

Sucralfate, a complex of aluminium hydroxide with sulfated sucrose, forms a strong gastrointestinal tract (GIT) mucosal barrier with excellent anti-ulcer property. Because sucralfate does not undergo any significant oral absorption, sucralfate resides in the GIT for a considerable length of time. The unabsorbed sucralfate may alter the pharmacokinetics of the oral drugs by impeding its absorpti…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Network pharmacology approach to investigate the molecular mechanism of DLBS2…
Comment Share
Rustan J

DLBS2411, a bioactive fraction of Cinnamomum burmannii, has been proven to exhibit its anti-ulcer properties through preclinical and clinical studies. However, the bioactive compounds, protein targets, and underlying molecular pathways are still poorly known. Therefore, network pharmacology was used in this study to understand the molecular mechanisms of DLBS2411 in treating gastritis. There…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-